Digital lifestyle tool plus a language model to help prevent type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests whether access to a Swedish digital lifestyle tool, enhanced with an AI-powered language model for guided reflection on expert health content, can reduce the incidence of type 2 diabetes. Participants are adults 35+ without diabetes, randomly assigned to receive the intervention or usual care, with no in-person visits or blood draws required. The primary outcome is new cases of type 2 diabetes over three years, as recorded in national health registers. The approach builds on prior work showing glycemic improvements with the lifestyle tool and aims to personalize user engagement through the LLM. Content is written by physicians and researchers and is designed to prompt daily-life application of health recommendations.

Why it matters

Who can join: the full rules

Inclusion criteria

* Informed consent
* Age above 35 years
* Access to Internet and mobile or computer device

Exclusion criteria

* diabetes mellitus
* conditions or treatments that in the judgement of the Investigator could affect the study evaluation
* connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected.
* living outside of Sweden
* inability to read and write in Swedish

Where it's running

• Clinical Research Center
  Malmö, Skåne County, Sweden Recruiting

Study contacts

• Principal investigator: Anders Rosengren, MD PhD — Göteborg University
• Study coordinator: Birgitta Abrahamsson, MSc
• Email: birgitta.x.abrahamsson@skane.se
• Phone: 0705316704

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.